Shares of Chelsea Therapeutics International Ltd CHTP spiked nearly 24% on Monday, after the company reported positive scientific data for Northera.
CHTP reported favorable Phase III data for its drug candidate Northera, for a chronic type of low blood pressure.
Chelsea's shares surged 24.31% to $1.23 at 10:45 am.
Shares of CHTP have advanced 42.54% over the past month and have risen 87.41% so far this year.
Read more from Benzinga's Company news.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsTrading IdeasBiotechnologyHealth Caremovers and shakers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in